Emmanuelle Josselin

1.6k total citations
20 papers, 1.1k citations indexed

About

Emmanuelle Josselin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Emmanuelle Josselin has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Emmanuelle Josselin's work include Wnt/β-catenin signaling in development and cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Synthesis and biological activity (2 papers). Emmanuelle Josselin is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Synthesis and biological activity (2 papers). Emmanuelle Josselin collaborates with scholars based in France, United States and Netherlands. Emmanuelle Josselin's co-authors include Daniel Birnbaum, Rémy Castellano, François Bertucci, Pascal Finetti, Olivier Cabaud, Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Laleh Majlessi, Claude Leclerc and Priscille Brodin and has published in prestigious journals such as PLoS ONE, Oncogene and Clinical Cancer Research.

In The Last Decade

Emmanuelle Josselin

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Josselin France 15 513 317 240 216 204 20 1.1k
Jinsong Hu China 19 747 1.5× 391 1.2× 278 1.2× 301 1.4× 344 1.7× 50 1.5k
Chih-Wei Lin Taiwan 16 534 1.0× 156 0.5× 267 1.1× 180 0.8× 83 0.4× 29 1.5k
Hein Schepers Netherlands 21 752 1.5× 284 0.9× 231 1.0× 221 1.0× 206 1.0× 34 1.4k
Carine Ervolino de Oliveira Brazil 20 367 0.7× 231 0.7× 182 0.8× 76 0.4× 218 1.1× 38 855
Melissa M. Schutten United States 17 592 1.2× 465 1.5× 143 0.6× 105 0.5× 74 0.4× 31 1.3k
Raquel Blanco Spain 15 1.4k 2.7× 403 1.3× 322 1.3× 105 0.5× 209 1.0× 18 1.9k
Ian R. Kelsall United Kingdom 14 815 1.6× 225 0.7× 403 1.7× 73 0.3× 159 0.8× 16 1.1k
Matthew W. VanBrocklin United States 15 617 1.2× 275 0.9× 190 0.8× 56 0.3× 126 0.6× 32 1.1k
Susana Orozco United States 11 918 1.8× 287 0.9× 658 2.7× 218 1.0× 196 1.0× 12 1.5k
Krishna Kumar India 13 407 0.8× 289 0.9× 437 1.8× 71 0.3× 105 0.5× 28 946

Countries citing papers authored by Emmanuelle Josselin

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Josselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Josselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Josselin more than expected).

Fields of papers citing papers by Emmanuelle Josselin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Josselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Josselin. The network helps show where Emmanuelle Josselin may publish in the future.

Co-authorship network of co-authors of Emmanuelle Josselin

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Josselin. A scholar is included among the top collaborators of Emmanuelle Josselin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Josselin. Emmanuelle Josselin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolodych, Sergii, Rémy Castellano, Emmanuelle Josselin, et al.. (2024). INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Molecular Cancer Therapeutics. 23(8). 1159–1175. 1 indexed citations
2.
Azim, Hatem A., Florence Lhospice, Xavier Préville, et al.. (2023). Abstract B128: Preclinical characterization of ETx-22, a next-generation antibody drug conjugate (ADC) targeting nectin-4. Molecular Cancer Therapeutics. 22(12_Supplement). B128–B128. 3 indexed citations
3.
Bernard, P, Rebecca B. Delconte, Sonia Pastor, et al.. (2022). Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. Journal for ImmunoTherapy of Cancer. 10(5). e004244–e004244. 48 indexed citations
4.
Lamballe, Fabienne, Yaron Vinik, Fabrice Daian, et al.. (2020). Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science. 8(3). 2003049–2003049. 25 indexed citations
5.
Josselin, Emmanuelle, Armelle Goubard, Rémy Castellano, et al.. (2019). A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer. Frontiers in Immunology. 10. 1593–1593. 54 indexed citations
6.
Karkeni, Esma, Armelle Goubard, Emmanuelle Josselin, et al.. (2019). Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer. Frontiers in Immunology. 10. 1307–1307. 61 indexed citations
7.
Sebbagh, Michaël, François Bertucci, Pascal Finetti, et al.. (2018). The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling. Stem Cell Reports. 11(5). 1040–1050. 15 indexed citations
8.
Morin, Aurélie, Carmen Ruggiero, Estelle Robidel, et al.. (2017). Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma. Oncotarget. 8(31). 51050–51057. 8 indexed citations
9.
Cabaud, Olivier, Emmanuelle Josselin, Pascal Finetti, et al.. (2016). Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Annals of Oncology. 28(4). 769–776. 103 indexed citations
10.
Daulat, Avais M., François Bertucci, Stéphane Audebert, et al.. (2016). PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2. Developmental Cell. 37(4). 311–325. 59 indexed citations
11.
Delalande, Olivier, Mickaël Jean, Rémy Castellano, et al.. (2015). A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells. Journal of Medicinal Chemistry. 58(16). 6559–6573. 33 indexed citations
12.
Fortugno, Paola, Emmanuelle Josselin, Konstantinos Tsiakas, et al.. (2014). Nectin-4 Mutations Causing Ectodermal Dysplasia with Syndactyly Perturb the Rac1 Pathway and the Kinetics of Adherens Junction Formation. Journal of Investigative Dermatology. 134(8). 2146–2153. 27 indexed citations
13.
Wicinski, Julien, Olivier Cabaud, Yves Toiron, et al.. (2013). The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression. Clinical Cancer Research. 19(23). 6520–6531. 113 indexed citations
14.
Berruyer-Pouyet, Carole, Olivier Cabaud, Emmanuelle Josselin, et al.. (2012). Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer. PLoS ONE. 7(9). e43409–e43409. 6 indexed citations
15.
Meurs, Illiana, Laura Calpe‐Berdiel, Kim L. L. Habets, et al.. (2012). Effects of Deletion of Macrophage ABCA7 on Lipid Metabolism and the Development of Atherosclerosis in the Presence and Absence of ABCA1. PLoS ONE. 7(3). e30984–e30984. 20 indexed citations
16.
Meurs, Illiana, Laura Calpe‐Berdiel, Kim L. L. Habets, et al.. (2012). Correction: Effects of Deletion of Macrophage ABCA7 on Lipid Metabolism and the Development of Atherosclerosis in the Presence and Absence of ABCA1. PLoS ONE. 7(5). 4 indexed citations
17.
Ginestier, Christophe, Florence Monville, Julien Wicinski, et al.. (2012). Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target. Stem Cells. 30(7). 1327–1337. 124 indexed citations
18.
Fournier, Gilles, Olivier Cabaud, Emmanuelle Josselin, et al.. (2011). Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth. Oncogene. 30(36). 3862–3874. 45 indexed citations
19.
Brancati, Francesco, Paola Fortugno, Irene Bottillo, et al.. (2010). Mutations in PVRL4, Encoding Cell Adhesion Molecule Nectin-4, Cause Ectodermal Dysplasia-Syndactyly Syndrome. The American Journal of Human Genetics. 87(2). 265–273. 91 indexed citations
20.
Frigui, Wafa, Daria Bottai, Laleh Majlessi, et al.. (2008). Control of M. tuberculosis ESAT-6 Secretion and Specific T Cell Recognition by PhoP. PLoS Pathogens. 4(2). e33–e33. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026